Establishment and internal validation of a model to predict the efficacy of Adalimumab in Crohn’s disease
Abstract Background: Clinically, the ability to distinguish which Crohn’s disease patients can benefit from Adalimumab is limited. Aims: This study aimed to develop a model for predicting clinical remission probability for Crohn’s disease patients with Adalimumab at 12 weeks. The model assists clini...
Saved in:
| Main Authors: | Fang Wang, He Zhou, Yujie Zhang, Yu Da, Tiantian Zhang, Yanting Shi, Tong Wu, Jie Liang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-01-01
|
| Series: | Scientific Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1038/s41598-024-82855-0 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Innovative Assessment of Crohn’s Disease: An Activity Prediction Tool Combining Laboratory Data and Imaging [Letter]
by: Wang F, et al.
Published: (2025-02-01) -
A nomogram for predicting small bowel mucosal healing in pediatric Crohn’s disease
by: Bingxia Chen, et al.
Published: (2025-06-01) -
Systemic Immune-Inflammation Index: A Promising, Non-Invasive Biomarker for Crohn’s Disease Activity and Severity Assessment
by: Deng Y, et al.
Published: (2025-01-01) -
Risk factor analysis and nomogram for predicting massive postoperative gastrointestinal bleeding in patients with Crohn’s disease: a multicenter retrospective study
by: Mengyi Zhang, et al.
Published: (2025-08-01) -
Adalimumab induced psoriasis in Crohn’s disease and treatment with ustekinumab: case report and special histopathological findings
by: Fang Qiu, et al.
Published: (2025-01-01)